Role of IL-23 neutralization in psoriasis – insights from a mechanistic PK/PD model and meta-analysis of clinical data
Keyword(s):
AbstractBlocking of IL-23 has shown a profound effect on patient outcomes in psoriasis. The current IL-23 binding monoclonal antibodies show differences in dosing regimens, pharmacokinetics, affinity for the target, and efficacy outcomes in the clinic. The goal of the current work is to use a mechanistic pharmacokinetics/pharmacodynamics mathematical model to estimate projected free IL-23 neutralization for the different therapeutic molecules and connect it to clinical efficacy outcomes. The meta-analysis indicates a sigmoid-like relationship and suggests that the best current anti-IL23 antibodies are close to saturating the efficacy that can be achieved by this pathway in psoriasis.
Keyword(s):
Keyword(s):
1992 ◽
Vol 44
(9)
◽
pp. 761-765
◽
2015 ◽
Vol 43
(4)
◽
pp. 471-482
◽
Keyword(s):
1992 ◽
Vol 44
(9)
◽
pp. 755-760
◽
1996 ◽
Vol 23
(S2)
◽
pp. S10-S12
◽